vol. 41 no. 2 109-114
- Received March 17, 2016.
- Accepted June 27, 2016.
- Published online 3 April 2017.
Copyright & Usage
© 2017 The Authors This is an open-access article published by the Royal College of Psychiatrists and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 1Niemann-Pick UK, Washington, UK
- 2The Mark Holland Metabolic Unit, Salford Royal Foundation NHS Trust, Manchester, UK
- Correspondence to Will Evans ( )
Declaration of interest W.R.H.E. is a trustee of NP-UK and C.J.H. is Director of FYMCA Medical and consultant for Amicus, Alexion, Actelion, BioMarin, Sanofi Genzyme and Shire.